Three decades after its introduction as an adjuvant therapeutic option in the management of
selective drug-resistant epilepsy cases (DRE), vagus nerve stimulation (VNS) retains …

Evidence‐based guidelines, or recommendations, for the management of infants with
seizures are lacking. A Task Force of the Commission of Pediatrics developed a consensus …

Status epilepticus (SE) treatment strategies vary substantially from one institution to another
due to the lack of data to support one treatment over another. To provide guidance for the …

Background Vagus nerve stimulation (VNS) is currently used to treat refractory epilepsy and
is being investigated as a potential therapy for a range of conditions, including heart failure …

Objectives To establish standards for early, cost-effective, and accurate diagnosis; optimal
therapies for seizures; and recommendations for evaluation and management of …

This fully updated edition of Developmental Neuropsychology: A Clinical Approach
addresses key issues in child neuropsychology with a unique emphasis on evidence …

Objective: To evaluate the evidence since the 1999 assessment regarding efficacy and
safety of vagus nerve stimulation (VNS) for epilepsy, currently approved as adjunctive …

BACKGROUND: Neuromodulation-based treatments have become increasingly important in
epilepsy treatment. Most patients with epilepsy treated with neuromodulation do not achieve …

Vagus nerve stimulation (VNS) was approved by the US FDA in 1997 as an adjunctive
treatment for medically refractory epilepsy. It is considered for use in patients who are poor …

Although the preceding chapters discuss much of the new knowledge of neurocircuitry of
neuropsychiatric diseases, and an invasive approach to treatment, this chapter describes …